You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

METHYLATED 06-methylguanine-DNA methyltransferase (MGMT)

Showing 1 - 25 of 4,504
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

Colorectal Cancer Trial in New Haven (Temozolomide + Olaparib)

Active, not recruiting
  • Colorectal Cancer
  • Temozolomide + Olaparib
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 17, 2022

Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Oxaliplatin-based chemotherapy
  • Alkylating-based chemotherapy
  • Amiens, France
  • +18 more
Mar 15, 2022

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083 (Dianhydrogalactitol)
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
Mar 23, 2022

O6-methylguanine-DNA Methyltransferase Promoter Methylation and

Active, not recruiting
  • Sarcoma
  • O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine treated sarcoma patients
  • Naples, Campania, Italy
    National Cancer Institute of Naples
May 14, 2021

Rectal Cancer Trial in Milan (External-beam radiation, Capecitabine, Temozolomide)

Recruiting
  • Rectal Cancer
  • External-beam radiation
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Jan 25, 2022

Advanced Rectal Cancer Trial in Seoul (Capecitabine plus temozolomide VS Capecitabine)

Unknown status
  • Advanced Rectal Cancer
  • Capecitabine plus temozolomide VS Capecitabine
  • Seoul, Songpa, Korea, Republic of
    Asan Medical Center
Jan 17, 2021

Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 30, 2023

Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

Recruiting
  • Colorectal Neoplasms
  • Microsatellite Instability
  • temozolomide (induction),
  • pembrolizumab (treatment)
  • Milano, Italy
  • +3 more
Sep 28, 2022

Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

Completed
  • Metastatic Colorectal Cancer
  • Milan, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

Not yet recruiting
  • Advanced Glioblastoma
  • +2 more
  • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
  • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
  • Ramat Gan, Israel
    Sheba medical center
Jun 11, 2023

Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

Recruiting
  • Recurrent IDH1/2 Mutated Glioma
  • Paris, France
    Pitie Salpetriere Hospital
Aug 29, 2022

Glioblastoma Multiforme Trial in Baltimore (Retifanlimab, Temozolomide, Radiation Therapy)

Recruiting
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    Johns Hopkins Medical Institution
Dec 5, 2022

Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)

Not yet recruiting
  • Glioblastoma
  • Glioma, Malignant
  • MT-201-GBM monocyte vaccine
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University M
May 25, 2022

Colorectal Cancer Trial (Irinotecan, Temozolomide)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 1, 2022

Metastatic Colorectal Cancer Trial in Milan (Bevacizumab, Irinotecan, Leucovorin)

Recruiting
  • Metastatic Colorectal Cancer
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

Withdrawn
  • MGMT-Methylated Glioblastoma
  • Delay of TMZ
  • Standard of Care (SOC) Adjuvant TMZ (no intervention
  • (no location specified)
Aug 5, 2022

Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Temozolomide capsule
  • Milan, Italy
    European Institute of Oncology, IEO, IRCCS
Sep 21, 2022

Adenocarcinoma - GEJ, Cancer of Esophagus Trial in Cambridge (Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month)

Recruiting
  • Adenocarcinoma - GEJ
  • Cancer of Esophagus
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Oct 6, 2021

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Malignant Glioma of Brain Trial in Chicago (Acetazolamide, Temozolomide)

Recruiting
  • Malignant Glioma of Brain
  • Chicago, Illinois
    University of Chicago Medical Center
Apr 1, 2022

Glioblastoma Trial in Boston (radiation, biological, drug)

Recruiting
  • Glioblastoma
  • Radiation Therapy
  • +3 more
  • Boston, Massachusetts
  • +1 more
May 31, 2022

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Glioblastoma Trial in Spain (Temozolomide)

Completed
Has Results
  • Glioblastoma
  • Badalona, Barcelona, Spain
  • +19 more
Dec 17, 2020